Introduction {#sec1-0300060516659575}
============

Acute viral hepatitis (AVH) is a common health problem throughout tropical countries in low socioeconomic groups.^[@bibr1-0300060516659575]^ Hepatitis A virus (HAV) and hepatitis E virus (HEV) are common causes of AVH and both are mainly transmitted through the faeco-oral route.^[@bibr1-0300060516659575]^ Egypt is known to have a high seroprevalence for HEV antibodies (anti-HEV); anti-HEV prevalence has been reported to be 84% in pregnant women and up to 60% in children aged 5--10 years.^[@bibr2-0300060516659575]^ Among Egyptians, the incidence of asymptomatic HEV seroconversion has been reported to be 42 per 1000 person-years, while the incidence of symptomatic AVH due to HEV infection was only 3 per 100 000 person-years.^[@bibr2-0300060516659575],[@bibr3-0300060516659575]^ However, HEV infection was reported to account for 12--42% of all cases of AVH in Egypt.^[@bibr4-0300060516659575]^

Infection with HEV is endemic in many developing countries and in recent years autochthonous and sporadic HEV infections have also been described in some developed countries.^[@bibr5-0300060516659575]^ HEV usually causes an acute self-limiting hepatitis, but fulminant hepatic failure resulting in morbidity and mortality may occur.^[@bibr6-0300060516659575]^ The purpose of the present study was to describe the epidemiological, clinical and laboratory data of hepatitis E virus (HEV) infection in a cohort of children from Assiut, Upper Egypt, who were part of a large multicentre prospective study of AVH.^[@bibr7-0300060516659575][@bibr8-0300060516659575]--[@bibr9-0300060516659575]^

Patients and methods {#sec2-0300060516659575}
====================

Data from a large multicentre prospective study of AVH^[@bibr7-0300060516659575][@bibr8-0300060516659575]--[@bibr9-0300060516659575]^ conducted at Assiut University Children's Hospital and Assiut Fever Hospital, Assiut, Egypt, from January 2007 to July 2008 were analysed. Subjects included in the present analysis were aged 2 to 18 years and had either been diagnosed with AVH based on symptoms of less than 1 month's duration that were compatible with acute hepatitis after exclusion of other potential non-viral causes of hepatocellular injury^[@bibr10-0300060516659575],[@bibr11-0300060516659575]^ or were close contacts of those with AVH who were found to have asymptomatic AVH. Patients with chronic liver disease and/or decompensated liver cirrhosis were excluded from the original study.

Data recorded for all study participants included a complete medical history, including possible routes and risks of hepatitis exposure in the previous 6 months, clinical examination, liver function tests and screening for hepatotropic viruses. Serological screening for HAV, hepatitis B virus (HBV) and hepatitis C virus (HCV) was performed using rapid tests for anti-HAV immunoglobulin M (IgM) (CTK Biotech, San Diego, CA, USA), anti-HBV core IgM (IND Diagnostic, Delta, Canada) and anti-HCV immunoglobulin G (IgG) (Clinpro International, Union City, CA, USA), respectively. HEV screening was performed using anti-HEV IgM and IgG kits (Adaltis, Guidonia Montecelio, Italy, and MP Diagnostics, Singapore) according to the manufacturers' instructions. A diagnosis of autoimmune hepatitis (AIH) was based on a clinical history and symptoms suggestive of an underlying autoimmune aetiology, together with a serological assay for antinuclear and anti-smooth muscle antibodies. Human Anti-nuclear antibodies (ANA) Screen ELISA test kit; Diagnostic Automation/ Cortez Diagnostics INC. Woodland Hills, California, USA. Human Anti-smooth muscle antibody, ASMA ELISA Kit; MyBioSource, Inc. San Diego, USA. Cytomegalovirus (CMV) infection was diagnosed in the presence of CMV IgM Human Anti-cytomegalovirus IgM antibody (anti-CMV-IgM) ELISA Kit; MyBioSource, Inc. San Diego, USA. The presence of Epstein--Barr virus (EBV) was not investigated because none of the patients showed any signs or symptoms of this type of infection. The presence of human hepatitis delta virus (HDV) was not investigated because this cohort of patients presented with symptoms of acute hepatitis in the absence of any known underlying chronic hepatitis infection, whereas HDV can only propagate in the presence of co-infecting HBV.^[@bibr12-0300060516659575]^ Moreover, patients with known chronic liver disease were excluded from the study.

The study was approved by the Ethics Committee of the National Hepatology and Tropical Medicine Research Institution, USA, and the Ethics Committee at the Faculty of Medicine, Assiut University, Egypt. Parents or legal guardians of eligible patients provided written informed consent on enrolment to the study.

Statistical analyses {#sec3-0300060516659575}
--------------------

Quantitative variables were expressed as the mean ± SD and compared between groups using the Student's *t-*test. Qualitative variables were compared between groups using the χ^2^ test or Fisher's exact test as appropriate. A *P*-value \< 0.05 was considered to be statistically significant. Data were analysed using IBM SPSS software version 20 for Windows® (IBM Corp, Armonk, NY, USA).

Results {#sec4-0300060516659575}
=======

From the records for patients or close contacts with AVH involved in a large multicentre study,^[@bibr7-0300060516659575][@bibr8-0300060516659575]--[@bibr9-0300060516659575]^ data for 123 children (73 boys, 50 girls) aged 2--18 years were analysed. Patient characteristics are given in [Table 1](#table1-0300060516659575){ref-type="table"}. In total, 110 (89.4%) children were symptomatic and 13 (10.6%) were asymptomatic. Table 1.Characteristics of children aged 2--18 years (*n* = 123) with acute viral hepatitis.Age, years6.4 ± 0.4Sex Male73 (59.3) Female50 (40.7)Residence Rural75 (61.0) Urban48 (39.0)Animal contact Yes27 (22.0) No96 (78.0)Water source Tap water96 (78.0) Underground well27 (22.0)Blood transfusion Yes2 (1.6) No121 (98.4)Clinical presentation Symptomatic110 (89.4) Asymptomatic13 (10.6)Fulminant disease Yes5 (4.1) No118 (95.9)Outcome Survived118 (95.9) Died5 (4.1)Type of infection Isolated infection^[a](#table-fn2-0300060516659575){ref-type="table-fn"}^79 (64.2) Mixed infection^[b](#table-fn3-0300060516659575){ref-type="table-fn"}^11 (8.9) Non hepatitis A--E viral infection33 (26.8)[^1][^2][^3]

Of the 123 children, 33 (26.8%) had isolated acute HEV infection, 17 (13.8%) had isolated HAV infection, 10 (8.1%) had isolated HBV infection, 14 (11.4%) had isolated CMV hepatitis, five (4.1%) had isolated AIH, 11 (8.9%) had hepatitis due to mixed viral infections and 33 (26.8%) were diagnosed with non A--E hepatitis ([Figure 1](#fig1-0300060516659575){ref-type="fig"}). Figure 1.Prevalence of different types of hepatitis among 123 children with acute viral hepatitis. HEV, hepatitis E virus; HAV, hepatitis A virus; HBV, hepatitis B virus; CMV, cytomegalovirus; AIH, autoimmune hepatitis.

Of the 11 children with mixed viral hepatitis, co-infection with HEV and HAV was found in three patients, HEV and HBV in two patients, HAV and HBV in three patients, HAV and acute HCV in one patient, and CMV with AIH in two patients. Therefore, overall 38 (30.9%) children were infected with HEV.

Of those with HEV infection, statistically significantly more patients used an underground well as a water source compared with a tap water source (*P* \< 0.001) ([Table 2](#table2-0300060516659575){ref-type="table"}). Although not statistically significant, animal contact was greater among children with HEV infection compared with those with non-HEV infection ([Table 2](#table2-0300060516659575){ref-type="table"}). Table 2.Characteristics and liver function test results in children aged 2--18 years (*n* = 123) with hepatitis E virus (HEV) hepatitis and non-HEV hepatitis.HEV infection *n* = 38Non-HEV infection *n* = 85Statistical significanceAge, yearsNS Mean ±  SD6.2 ± 0.56.5 ± 0.5 Range2--172--18SexNS Male19 (50.0)54 (63.5) Female19 (50.0)31 (36.5)ResidenceNS Rural22 (57.9)53 (62.4) Urban16 (42.1)32 (37.6)Animal contactNS Yes12 (31.6)15 (17.6) No26 (68.4)70 (82.4)Water source*P* \< 0.001 Tap water12 (31.6)84 (98.8) Underground  well26 (68.4)1 (1.2)Blood transfusionNS Yes1 (2.6)1 (1.2) No37 (97.4)84 (98.8)Fulminant diseaseNS Yes1 (2.6)4 (4.7) No37 (97.4)81 (95.3)OutcomeNS Survived37 (97.4)81 (95.3) Died1 (2.6)4 (4.7)Liver function tests Total  bilirubin,  mg/dl6.0 ± 1.25.6 ± 0.6NS Direct  bilirubin,  mg/dl4.7 ± 1.04.6 ± 0.5NS ALT, IU/l55 ± 780 ± 3*P* \< 0.001 AST, IU/l41 ± 571 ± 3*P* \< 0.001[^4][^5][^6]

No statistically significant differences were found between those with HEV infection and those with non-HEV infection with regard to age, sex, residence, history of blood transfusion, disease severity or outcome. While no differences were detected between the two groups in terms of serum total or direct bilirubin, significantly higher levels of alanine aminotransferase and aspartate aminotransferase were observed in those with non-HEV infection compared with those with HEV infection (*P* \< 0.001) ([Table 2](#table2-0300060516659575){ref-type="table"}).

Discussion {#sec5-0300060516659575}
==========

Hepatitis E virus is an enterically transmitted pathogen that usually results in a self-limiting infection.^[@bibr13-0300060516659575]^ It is known to be endemic in many developing countries, and is responsible for both sporadic and epidemic outbreaks in developed countries.^[@bibr5-0300060516659575]^

In the present study, the prevalence rates of the different causes of AVH were comparable with other studies from Egypt, which have reported rates of 0.7--44% for HAV and 12--42% for HEV, with fewer cases being caused by HDV, CMV or EBV.^[@bibr14-0300060516659575]^ In a study from the Nile Delta, of the patients with AVH across all age groups, 8.5% had anti-HAV IgM, 4.3% had anti-hepatitis B surface antigen (HBsAg) antibodies, 78.7% had anti-HCV antibodies, 70.2% had HCV RNA, 2.1% had anti-HEV IgM and 85.1% had anti-HEV IgG; all patients were negative for anti-hepatitis B core IgM and HEV RNA.^[@bibr3-0300060516659575]^

In the present study, 38 (30.9%) out of 123 children with AVH had HEV infection, and of all the hepatotropic viruses it was the most common cause of AVH. Soliman^[@bibr14-0300060516659575]^ reported that 29.2% of patients with AVH in nine villages in the Giza Governorate of Eygpt were seropositive for anti-HEV IgG. In addition, HEV was found to account for 15--40% of adult and paediatric cases of AVH requiring hospitalization to Eygptian fever hospitals.^[@bibr13-0300060516659575]^ In a study conducted in the Nile Delta the seroprevalence rate for HEV in children below the age of 10 years was 57%,^[@bibr15-0300060516659575]^ and in a further study from a fever hospital in Alexandria, 78% of patients with AVH between 15 and 40 years of age were anti-HEV IgM positive.^[@bibr16-0300060516659575]^ In contrast, HEV infection is relatively rare in paediatric age groups in Turkey and Morocco, where rates of 5% have been reported in children under the age of 10 years.^[@bibr17-0300060516659575],[@bibr18-0300060516659575]^ Differences between studies in the prevalence of acute HEV infection may be due to variability in the sociodemographic and socioeconomic characteristics of populations, sanitary conditions, sewage disposal and diagnostic procedural methods.^[@bibr9-0300060516659575]^

The finding in the present study that 8.9% of the children with AVH had mixed hepatitis infection was comparable with the results of a study involving 162 children from Mansoura, Egypt.^[@bibr19-0300060516659575]^ In that study, the HEV co-infection rate among patients with non A--C hepatitis was 7.1%, and anti-HEV IgM antibodies were detected in 4.5% of patients with HAV and in 3.3% of patients with HBV. Similarly, in a study based in a fever hospital in Suez, of the 14.9% of patients who were positive for anti-HEV IgM, only 2.8% showed positivity for anti-HEV IgM alone, with 5.0% also being positive for anti-HAV, 0.7% also being positive for HBsAg, 1.4% also being positive for anti-HCV and 5.0% also being positive for anti-CMV.^[@bibr20-0300060516659575]^

In the present study, there were no differences between children with AVH with HEV infection and those with non-HEV infection in terms of age, sex, type of residence area, animal contact, blood transfusion, disease severity or outcome. These findings are in agreement with other studies that have shown that HEV infection is independent of sex and residence area.^[@bibr18-0300060516659575],[@bibr21-0300060516659575][@bibr22-0300060516659575]--[@bibr23-0300060516659575]^ However, a higher prevalence for HEV infection in males has been reported in Japan^[@bibr24-0300060516659575]^ and Pakistan,^[@bibr25-0300060516659575]^ while in Italy more women than men were demonstrated to have HEV antibodies.^[@bibr26-0300060516659575]^ A study of the prevalence of HEV antibodies among apparently healthy Egyptians in different age groups found that HEV was endemic in Egypt, especially in rural areas, and there was no significant relationship between HEV and sex but there was a significant relationship with type of residence area, crowded living conditions and poor sanitation, which are important factors in the transmission of the virus.^[@bibr27-0300060516659575]^

In the present study, significantly more individuals with AVH used underground wells as a water source (68.4%) compared with a tap-water source (31.6%). Water from underground wells is not chlorinated and so is thought to be at higher risk of contamination with the virus. In a study from Northern Egypt, contaminated drinking water was found to be the main source of HEV infection.^[@bibr28-0300060516659575]^ Interestingly, in the present study, most of the children who used water from an underground well were from the same village and used the same well. However, the virus could not be isolated from the underground well water or from the sewage of that geographical area. This may have been due to the time lag between the outbreak of the HEV infection and when the samples were taken a few months later.

While in the present study animal contact did not appear to be associated with HEV infection, virological evidence of mammalian HEV has been found in domestic pigs, wild boar, deer, mongoose, cats, dogs, cattle, sheep, goats, horses, macaques, donkeys, rats and mice.^[@bibr29-0300060516659575]^ Similarly, although no association was found in the present study between a history of blood transfusion and HEV infection, blood-borne HEV infection has been reported following blood transfusion.^[@bibr30-0300060516659575]^

As in other studies,^[@bibr4-0300060516659575],[@bibr31-0300060516659575]^ the clinical presentation of acute HEV infection was indistinguishable from AVH due to other viral causes. Disease severity at the time of presentation, evaluated by the presence of fulminant disease, showed no significant difference between patients with HEV infection and those with non-HEV infection (2.6% and 4.7%, respectively). These findings are similar to other reports that have shown that, for most patients, HEV infection is a benign and self-limiting disease, although its severity may be affected by its genotype.^[@bibr31-0300060516659575]^ The low mortality observed in the present study is also consistent with other reports that have estimated overall mortality rates from HEV infection to be between 0.5% and 4%.^[@bibr1-0300060516659575]^ Nevertheless, one study among Egyptian children under the age of 10 years with HEV infection reported a higher mortality rate.^[@bibr32-0300060516659575]^

In the present study, the non-significant differences in serum total and direct bilirubin levels between children with HEV infection and those with non-HEV infection are similar to the findings of other studies.^[@bibr33-0300060516659575],[@bibr34-0300060516659575]^ However, liver enzymes were significantly higher among those with non-HEV infection compared with those with HEV infection.

One limitation of the study was the failure to isolate HEV from the underground well water and sewage from the geographical area that showed a high prevalence of infection with HEV. Another limitation was the lack of polymerase chain reaction testing for CMV or EBV, although CMV IgM was assessed in patients who were negative for the common hepatotropic viruses.

In Upper Egypt, HEV infection is a significant cause of AVH among children and is difficult to distinguish clinically from other acute hepatotropic viral infections. Screening for HEV should be considered among all Egyptian children with AVH. More health education programmes and the development of new vaccines against HEV will also help to protect children from this infection.
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[^1]: Data presented as mean ± SD or *n* (%).

[^2]: Hepatitis due to a single hepatotropic virus.

[^3]: Hepatitis due to more than one hepatotropic virus.

[^4]: Data presented as mean ± SD or *n* (%).

[^5]: ALT, alanine aminotransferase; AST, aspartate aminotransferase.

[^6]: NS, no statistically significant between-group differences (*P* ≥ 0.05) using Student's *t*-test for quantitative variables and χ^2^ test or Fisher's exact test for qualitative variables.
